Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode™ Whole Transcriptome ...
BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study ...
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced a significant update to the company’s flagship Evercode™ ...
Scientists can peer into cells to get a limited view of their activity using microscopes and other tools. However, cells and the molecular events within them are dynamic, and developmental processes, ...
Evaluation of 68Ga-FAPI PET/CT and 18F-FDG PET/CT for the primary staging of non-small cell lung cancer (NSCLC). Application of an epigenomic-based classifier to identify cancer signal of origin on ...
Wheat is the most widely cultivated crop in the world; over 215 million hectares are grown annually. To meet the demands of a growing global population, plant breeders face the challenge of increasing ...